These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 15575245)
1. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol. Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245 [TBL] [Abstract][Full Text] [Related]
2. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension]. Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337 [No Abstract] [Full Text] [Related]
3. Sildenafil treatment of primary pulmonary hypertension. Laupland KB; Helmersen D; Zygun DA; Viner SM Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621 [TBL] [Abstract][Full Text] [Related]
4. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate. Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385 [TBL] [Abstract][Full Text] [Related]
5. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Abrams D; Schulze-Neick I; Magee AG Heart; 2000 Aug; 84(2):E4. PubMed ID: 10908271 [TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512 [TBL] [Abstract][Full Text] [Related]
7. [Hopes and experiences in the treatment of severe pulmonary hypertension]. Monserrat L; Penas Lado M; Castro-Beiras A Rev Esp Cardiol; 2003 Mar; 56(3):228-9. PubMed ID: 12622951 [No Abstract] [Full Text] [Related]
8. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470 [TBL] [Abstract][Full Text] [Related]
9. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary arterial hypertension: combination therapy in the modern management era. Sitbon O Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195 [No Abstract] [Full Text] [Related]
13. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478 [TBL] [Abstract][Full Text] [Related]
14. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy? Pitsiou GG; Chavouzis N; Nakou C; Boutou AK; Argyropoulou P; Stanopoulos I J Heart Lung Transplant; 2009 Jun; 28(6):651-3. PubMed ID: 19481029 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325 [TBL] [Abstract][Full Text] [Related]
16. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion? Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133 [TBL] [Abstract][Full Text] [Related]
17. Sildenafil as a treatment for pulmonary hypertension. Carroll WD; Dhillon R Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112 [TBL] [Abstract][Full Text] [Related]
18. Bosentan for the treatment of portopulmonary hypertension. Tempe DK; Datt V; Datta D Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763 [No Abstract] [Full Text] [Related]
19. [Combined treatment with intravenous prostacyclin and sildenafil in patients with pulmonary hypertension: report of 4 cases]. García Hernández FJ; Ocaña Medina C; Mateos Romero L; Martínez Martínez A; Bautista Lorite A; Santos Ramos B; Sánchez Román J Med Clin (Barc); 2004 Jan; 122(2):64-6. PubMed ID: 14733859 [TBL] [Abstract][Full Text] [Related]
20. Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study. Pavelescu A; Naeije R Eur J Appl Physiol; 2012 Apr; 112(4):1285-94. PubMed ID: 21785860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]